Vericel Corp Ord Stock Analysis

VCEL Stock  USD 37.05  1.09  3.03%   
Below is the normalized historical share price chart for Vericel Corp Ord extending back to February 04, 1997. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Vericel Corp stands at 37.05, as last reported on the 17th of February 2026, with the highest price reaching 37.05 and the lowest price hitting 34.13 during the day.
IPO Date
4th of February 1997
200 Day MA
37.5797
50 Day MA
36.9842
Beta
1.228
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Vericel Corp Ord holds a debt-to-equity ratio of 0.275. At this time, Vericel Corp's Debt To Assets are quite stable compared to the past year. Long Term Debt To Capitalization is expected to rise to 0.40 this year, although the value of Short and Long Term Debt will most likely fall to about 360 K. Vericel Corp's financial risk is the risk to Vericel Corp stockholders that is caused by an increase in debt.

Asset vs Debt

Equity vs Debt

Vericel Corp's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Vericel Corp's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Vericel Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Vericel Corp's stakeholders.
For many companies, including Vericel Corp, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Vericel Corp Ord, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Vericel Corp's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book
5.652
Enterprise Value Ebitda
74.9117
Price Sales
7.0295
Shares Float
50 M
Wall Street Target Price
55
At this time, Vericel Corp's Common Stock is quite stable compared to the past year. Stock Based Compensation is expected to rise to about 44.1 M this year, although the value of Sale Purchase Of Stock will most likely fall to about 4 M. . At this time, Vericel Corp's Price Earnings Ratio is quite stable compared to the past year. Price To Operating Cash Flows Ratio is expected to rise to 55.69 this year, although Price Book Value Ratio will most likely fall to 4.46.
Vericel Corp Ord is undervalued with Real Value of 46.32 and Target Price of 55.0. The main objective of Vericel Corp stock analysis is to determine its intrinsic value, which is an estimate of what Vericel Corp Ord is worth, separate from its market price. There are two main types of Vericel Corp's stock analysis: fundamental analysis and technical analysis.
The Vericel Corp stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued.

Vericel Stock Analysis Notes

About 99.0% of the company outstanding shares are owned by institutional investors. The company has Price/Earnings (P/E) ratio of 357.33. Vericel Corp Ord had not issued any dividends in recent years. The entity had 1:20 split on the 16th of October 2013. Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts. Vericel operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 281 people. For more information please call Dominick Esq at 617 588 5555 or visit https://www.vcel.com.

Vericel Corp Ord Investment Alerts

Vericel Corp Ord generated a negative expected return over the last 90 days
Vericel Corp Ord has a poor financial position based on the latest SEC disclosures
Over 99.0% of the company outstanding shares are owned by institutional investors
Latest headline from MacroaxisInsider: Acquisition by Mclaughlin Kevin F of 7000 shares of Vericel Corp at 2.63 subject to Rule 16b-3

Vericel Largest EPS Surprises

Earnings surprises can significantly impact Vericel Corp's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-07-31
2025-06-30-0.03-0.010.0266 
2024-08-01
2024-06-30-0.08-0.1-0.0225 
2020-05-05
2020-03-31-0.08-0.1-0.0225 
View All Earnings Estimates

Vericel Corp Environmental, Social, and Governance (ESG) Scores

Vericel Corp's ESG score is a quantitative measure that evaluates Vericel Corp's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Vericel Corp's operations that may have significant financial implications and affect Vericel Corp's stock price as well as guide investors towards more socially responsible investments.

Vericel Stock Institutional Investors

Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
William Blair Investment Management, Llc2025-06-30
1.2 M
Federated Hermes Inc2025-06-30
1.1 M
Bnp Paribas Investment Partners Sa2025-06-30
1.1 M
Royal Bank Of Canada2025-06-30
1.1 M
Loomis, Sayles & Company Lp2025-06-30
M
Champlain Investment Partners, Llc2025-06-30
997.3 K
New York State Common Retirement Fund2025-06-30
890.5 K
Allspring Global Investments Holdings, Llc2025-06-30
859.5 K
Capital Research Global Investors2025-06-30
853.7 K
Blackrock Inc2025-06-30
7.6 M
Vanguard Group Inc2025-06-30
3.6 M
Note, although Vericel Corp's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Vericel Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.82 B.

Vericel Profitablity

The company has Profit Margin (PM) of 0.05 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.05 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.05.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.02  0.02 
Return On Capital Employed 0.01  0.01 
Return On Assets 0.02  0.02 
Return On Equity 0.03  0.03 

Management Efficiency

Vericel Corp Ord has return on total asset (ROA) of 0.0105 % which means that it generated a profit of $0.0105 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0452 %, meaning that it created $0.0452 on every $100 dollars invested by stockholders. Vericel Corp's management efficiency ratios could be used to measure how well Vericel Corp manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is expected to rise to 0.02 this year. Return On Capital Employed is expected to rise to 0.01 this year. At this time, Vericel Corp's Intangible Assets are quite stable compared to the past year. Return On Tangible Assets is expected to rise to 0.02 this year, although the value of Non Currrent Assets Other will most likely fall to about 475.4 K.
Last ReportedProjected for Next Year
Book Value Per Share 6.87  6.53 
Tangible Book Value Per Share 6.73  6.39 
Enterprise Value Over EBITDA 146.49  153.82 
Price Book Value Ratio 8.27  4.46 
Enterprise Value Multiple 146.49  153.82 
Price Fair Value 8.27  4.46 
Enterprise Value1.6 B1.7 B
Vericel Corp Ord benefits from a proactive management team that anticipates market trends. Our analysis delves into how this proactive stance influences financial metrics and stock valuation.
Operating Margin
0.0511
Profit Margin
0.0506
Beta
1.228
Return On Assets
0.0105
Return On Equity
0.0452

Technical Drivers

As of the 17th of February 2026, Vericel Corp has the Variance of 8.5, coefficient of variation of (3,592), and Risk Adjusted Performance of (0.02). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vericel Corp Ord, as well as the relationship between them. Please validate Vericel Corp Ord market risk adjusted performance, variance, as well as the relationship between the Variance and value at risk to decide if Vericel Corp is priced more or less accurately, providing market reflects its prevalent price of 37.05 per share. Given that Vericel Corp Ord has information ratio of (0.05), we advise you to double-check Vericel Corp Ord's current market performance to make sure the company can sustain itself at a future point.

Vericel Corp Ord Price Movement Analysis

Execute Study
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Vericel Corp middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Vericel Corp Ord. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Vericel Corp Ord Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Vericel Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Vericel Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Vericel Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Mclaughlin Kevin F few days ago
Acquisition by Mclaughlin Kevin F of 7000 shares of Vericel Corp at 2.63 subject to Rule 16b-3
 
Wotton Paul K over two months ago
Disposition of 2500 shares by Wotton Paul K of Vericel Corp at 37.83 subject to Rule 16b-3
 
Wotton Paul K over two months ago
Disposition of 2500 shares by Wotton Paul K of Vericel Corp at 37.97 subject to Rule 16b-3
 
Jonathan Siegal over three months ago
Acquisition by Jonathan Siegal of 938 shares of Vericel Corp subject to Rule 16b-3
 
Hopper Jonathan Mark over three months ago
Acquisition by Hopper Jonathan Mark of 10000 shares of Vericel Corp at 18.0 subject to Rule 16b-3
 
Mclaughlin Kevin F over six months ago
Acquisition by Mclaughlin Kevin F of 7000 shares of Vericel Corp at 2.76 subject to Rule 16b-3
 
Hopper Jonathan Mark over six months ago
Acquisition by Hopper Jonathan Mark of 10000 shares of Vericel Corp at 18.0 subject to Rule 16b-3
 
Colangelo Dominick over six months ago
Acquisition by Colangelo Dominick of 14063 shares of Vericel Corp at 2.65 subject to Rule 16b-3
 
Colangelo Dominick over six months ago
Acquisition by Colangelo Dominick of 14062 shares of Vericel Corp at 2.65 subject to Rule 16b-3
 
Karen Mahoney over six months ago
Acquisition by Karen Mahoney of 5175 shares of Vericel Corp subject to Rule 16b-3
 
Colangelo Dominick over six months ago
Acquisition by Colangelo Dominick of 24850 shares of Vericel Corp at 2.75 subject to Rule 16b-3
 
Hopper Jonathan Mark over six months ago
Acquisition by Hopper Jonathan Mark of 1500 shares of Vericel Corp subject to Rule 16b-3

Vericel Corp Outstanding Bonds

Vericel Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Vericel Corp Ord uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Vericel bonds can be classified according to their maturity, which is the date when Vericel Corp Ord has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Vericel Corp Predictive Daily Indicators

Vericel Corp intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Vericel Corp stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Vericel Corp Corporate Filings

F5
13th of February 2026
The annual filing required by the Securities and Exchange Commission (SEC) from company insiders or beneficial owners
ViewVerify
8K
13th of January 2026
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
9th of January 2026
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
12th of December 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
4th of December 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
13th of November 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
12th of November 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
13A
10th of November 2025
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify

Vericel Corp Forecast Models

Vericel Corp's time-series forecasting models are one of many Vericel Corp's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Vericel Corp's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Vericel Corp Bond Ratings

Vericel Corp Ord financial ratings play a critical role in determining how much Vericel Corp have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Vericel Corp's borrowing costs.
Piotroski F Score
4
PoorView
Beneish M Score
(3.04)
Unlikely ManipulatorView

Vericel Corp Ord Debt to Cash Allocation

Many companies such as Vericel Corp, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Vericel Corp Ord currently holds 98.85 M in liabilities with Debt to Equity (D/E) ratio of 0.28, which may suggest the company is not taking enough advantage from borrowing. Vericel Corp Ord has a current ratio of 6.08, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Vericel Corp's use of debt, we should always consider it together with its cash and equity.

Vericel Corp Total Assets Over Time

Vericel Corp Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Vericel Corp uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Vericel Corp Debt Ratio

    
  22.0   
It seems most of the Vericel Corp's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Vericel Corp's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Vericel Corp, which in turn will lower the firm's financial flexibility.

Vericel Corp Corporate Bonds Issued

Vericel Short Long Term Debt Total

Short Long Term Debt Total

119.36 Million

At this time, Vericel Corp's Short and Long Term Debt Total is quite stable compared to the past year.

About Vericel Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Vericel Corp prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Vericel shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Vericel Corp. By using and applying Vericel Stock analysis, traders can create a robust methodology for identifying Vericel entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.05  0.05 
Operating Profit Margin 0.02  0.02 
Net Profit Margin 0.05  0.05 
Gross Profit Margin 0.83  0.79 

Current Vericel Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Vericel analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Vericel analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceConsensus# of Analysts
55.0Strong Buy8Odds
Vericel Corp Ord current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Vericel analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Vericel stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Vericel Corp Ord, talking to its executives and customers, or listening to Vericel conference calls.
Vericel Analyst Advice Details

Vericel Stock Analysis Indicators

Vericel Corp Ord stock analysis indicators help investors evaluate how Vericel Corp stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Vericel Corp shares will generate the highest return on investment. By understating and applying Vericel Corp stock analysis, traders can identify Vericel Corp position entry and exit signals to maximize returns.
Begin Period Cash Flow86.9 M
Common Stock Shares Outstanding51.7 M
Total Stockholder Equity292 M
Total Cashflows From Investing Activities-79 M
Tax Provision148 K
Quarterly Earnings Growth Y O Y0.476
Property Plant And Equipment Net173.3 M
Cash And Short Term Investments116.2 M
Cash74.5 M
Accounts Payable23.8 M
Net Debt24.3 M
50 Day M A36.9842
Total Current Liabilities50.3 M
Other Operating Expenses232.7 M
Non Current Assets Total219.9 M
Forward Price Earnings48.5437
Non Currrent Assets Other556 K
Stock Based Compensation36.5 M
When determining whether Vericel Corp Ord is a strong investment it is important to analyze Vericel Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vericel Corp's future performance. For an informed investment choice regarding Vericel Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Vericel Corp assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth
0.476
Earnings Share
0.26
Revenue Per Share
5.168
Quarterly Revenue Growth
0.166
Return On Assets
0.0105
Investors evaluate Vericel Corp Ord using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Vericel Corp's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Vericel Corp's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Vericel Corp's market price signifies the transaction level at which participants voluntarily complete trades.